Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Dataset wrap
Namers
Rowcaps
Rows 1-3: Show the Target Response (RSTESTCD = "TRGRESP") and Non-Target Response (RSTESTCD = "NTRGRESP") tests and corresponding Overall Response (RSTESTCD = "OVRLRESP") at the week 6 assessment.  The RSLNKGRP is populated on the Overall Response record only. The RSLNKGRP is used to associate underlying data in other domains to the Overall Response. 
Rows 4-12: Show the week 12, week 20 and week 28 responses. 
Row 13
Rows 13-20: At week 36, the New Lesion Progression (RSTESTCD = "NEWLPROG") test is used to represent an equivocal new lesion (RSORRES = "EQUIVOCAL") and to represent at week 44 that there are unequivocal new lesions (RSORRES = "UNEQUIVOCAL"). 
Dataset2
RowSTUDYIDDOMAINUSUBJIDRSSEQRSLNKGRPRSTESTCDRSTESTRSCATRSORRESRSSTRESCRSNAMRSEVALRSEVALIDEPOCHVISITNUMVISITRSDTCRSDY
1EX11111RS900111
TRGRESPTarget ResponseRECIST 1.1NENERADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT40WEEK 62010-02-1644
2EX11111RS900112
NTRGRESPNon-Target ResponseRECIST 1.1NENERADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT40WEEK 62010-02-1644
3EX11111RS900113R-A2OVRLRESPOverall ResponseRECIST 1.1NENERADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT40WEEK 62010-02-1644
4EX11111RS900114
TRGRESPTarget ResponseRECIST 1.1SDSDRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT60WEEK 122010-03-2985
5EX11111RS900115
NTRGRESPNon-Target ResponseRECIST 1.1NON-CR/NON-PDNON-CR/NON-PDRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT60WEEK 122010-03-2985
6EX11111RS900116R-A3OVRLRESPOverall ResponseRECIST 1.1SDSDRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT60WEEK 122010-03-2985
7EX11111RS900117
TRGRESPTarget ResponseRECIST 1.1PRPRRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT80WEEK 202010-05-30147
8EX11111RS900118
NTRGRESPNon-Target ResponseRECIST 1.1NON-CR/NON-PDNON-CR/NON-PDRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT80WEEK 202010-05-30147
9EX11111RS900119R-A4OVRLRESPOverall ResponseRECIST 1.1PRPRRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT80WEEK 202010-05-30147
10EX11111RS9001110
TRGRESPTarget ResponseRECIST 1.1PRPRRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT100WEEK 282010-07-25203
11EX11111RS9001111
NTRGRESPNon-Target ResponseRECIST 1.1NON-CR/NON-PDNON-CR/NON-PDRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT100WEEK 282010-07-25203
12EX11111RS9001112R-A5OVRLRESPOverall ResponseRECIST 1.1PRPRRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT100WEEK 282010-07-25203
13EX11111RS9001113
TRGRESPTarget ResponseRECIST 1.1CRCRRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT120WEEK 362010-09-17257
14EX11111RS9001114
NTRGRESPNon-Target ResponseRECIST 1.1CRCRRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT120WEEK 362010-09-17257
15EX11111RS9001115
NEWLPROGNew Lesion ProgressionRECIST 1.1EQUIVOCALEQUIVOCALRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT120WEEK 362010-09-17257
16EX11111RS9001116R-A6OVRLRESPOverall ResponseRECIST 1.1CRCRRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT120WEEK 362010-09-17257
17EX11111RS9001117
TRGRESPTarget ResponseRECIST 1.1PDPDRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 442010-11-14313
18EX11111RS9001118
NTRGRESPNon-Target ResponseRECIST 1.1CRCRRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 442010-11-14313
19EX11111RS9001119
NEWLPROGNew Lesion ProgressionRECIST 1.1UNEQUIVOCALUNEQUIVOCALRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 442010-11-14313
20EX11111RS9001120R-A7OVRLRESPOverall ResponseRECIST 1.1PDPDRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 442010-11-14313

...

Dataset wrap
Nametu
Rowcaps
Rows 1-6: Show a subject with 4 target lesions with TULNKID "R-T01"-"R-T04" and 2 non-target lesions with TULNKID "R-NT01" and "R-NT02" identified at screening. "R-T01" and "R-T02" target lesions are lymph nodes. "R-T01" is located in the supraclavicular lymph node (TULOC = "SUPRACLAVICULAR LYMPH NODE") on the right side (TULAT = "RIGHT"). The TULOC contains the location from the anatomical location terminology.  Note that some locations contain in the anatomical location controlled terminology contain laterality and/or directionality.  The laterality should not generally be added to TULOC unless in the controlled terminology, likewise for directionality.
Row 7: Shows at week 36, an equivocal new lesion (TULNKID = "R-NEW01") was identified in the left lower lobe of the lung (TULOC = "LUNG, LEFT LOWER LOBE").  In this instance, "LUNG, LEFT LOWER LOBE" is a published controlled term for anatomical location.
Row 8-9: Show at week 44, new unequivocal new lesions (TULNKID = "R-NEW02" and "R-NEW03") were identified in the cerebellum (TULOC = "CEREBELLUM") and the femoral lymph node (TULOC = "FEMORAL LYMPH NODE").
Dataset2
RowSTUDYIDDOMAINUSUBJIDTUSEQTUREFIDTULNKIDTUTESTCDTUTESTTUORRESTUSTRESCTULOCTULATTUDIRTUMETHODTUNUMTUEVALTUEVALIDEPOCHVISITNUMVISITTUDTCTUDY

1

EX11111TU900111IMG-00001R-T01TUMIDENTTumor IdentificationTARGETTARGETSUPRACLAVICULAR LYMPH NODERIGHT
MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTSCREEN10SCREENING2010-01-01-3
2EX11111TU900112IMG-00002R-T02TUMIDENTTumor IdentificationTARGETTARGETTHORACIC LYMPH NODE

CT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTSCREEN10SCREENING2010-01-02-2
3EX11111TU900113IMG-00001R-T03TUMIDENTTumor IdentificationTARGETTARGETTHYROID GLANDLEFT
MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTSCREEN10SCREENING2010-01-01-3
4EX11111TU900114IMG-00003R-T04TUMIDENTTumor IdentificationTARGETTARGETSKIN OF THE TRUNK
UPPERPHOTOGRAPHYRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTSCREEN10SCREENING2010-01-03-1
5EX11111TU900115IMG-00002R-NT01TUMIDENTTumor IdentificationNON-TARGETNON-TARGETMEDIASTINAL LYMPH NODERIGHT
CT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTSCREEN10SCREENING2010-01-02-2
6EX11111TU900116IMG-00001R-NT02TUMIDENTTumor IdentificationNON-TARGETNON-TARGETCEREBELLUMRIGHT
MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTSCREEN10SCREENING2010-01-011
7EX11111TU900117IMG-00020R-NEW01TUMIDENTTumor IdentificationNEWNEWLUNG, LEFT LOWER LOBE

CT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT120WEEK 362010-09-17257
8EX11111TU900118IMG-00019R-NEW02TUMIDENTTumor IdentificationNEWNEWCEREBELLUMLEFT
MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 442010-11-18317
9EX11111TU900119IMG-00022R-NEW03TUMIDENTTumor IdentificationNEWNEWFEMORAL LYMPH NODELEFT
ULTRASOUNDRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 442010-11-18317

...

Dataset wrap
Nametr
Rowcaps
Rows 1-6: Show the screening identification of the target and non-target lesions. For lymph node target lesions "R-T01" and "RT02" the TRTESTCD used for the assessments are "LPREP" and "LNSTATE". For non-lymph node target lesions "R-T03" and "R-T04" the TRTESTCD used for the assessments is "LDIAM".
Rows 7-8: Show the results for the Target lesions as a group (TRGRPID = "TARGET"). The TRTESTCDs are Sum of Diameter (TRTESTCD = "SUMDIAM") and Sum Diameters of Non Lymph Node Tumors (TRTESTCD = "SUMNLNLD").
Rows 9-10: Show the results for the non-targets. "R-NT01" is a lymph node where the TRTEST used for the assessments is "Lymph Node State" (TRTESTCD = "LNSTATE"). "R-NT02" is a non-lymph node where the TRTESTCD used for the assessments is Tumor State (TRTESTCD = "TUMSTATE").
Row 16:Shows a case where TRSTAT is "NOT DONE" with the reason for the result being not done as TRTEST of Longest Diameter with TRREASND as "SCAN NOT PERFORMED". 
Rows 17-21:Show the week 6 results for the Target lesions as a group (TRGRPID = "TARGET"). The TRTESTCDs used for the assessments are: "SUMDIAM", "SUMNLNLD", "ACNSD", "PCBSD" and "PCNSD". Within Row 20, the PCBSD could not be calculated because "R-T04" was not measured. TRSTAT is assigned "NOT DONE" and TRREASND contains the reason, in this case at least one target lesion was not measured.
Rows 22-23:Show the week 6 that "R-NT02" was not not evaluable and the results the "R-NT01" non-target lesion using TRTESTCD as TUMSTATE. 
Rows 30-34: Show the week 12 results for the Target lesions as a group (TRGRPID = "TARGET"). The TRTESTCDs used for the assessments are: "SUMDIAM", "SUMNLNLD", "ACNSD", "PCBSD" and "PCNSD".
Row 70: Shows the Sum Diameters of Non Lymph node Tumors (TRTESTCD = "SUMNLNLD") is "0". This means that the non-lymph node target tumors are all absent.  
Dataset2
RowSTUDYIDDOMAINUSUBJIDTRSEQTRGRPIDTRREFIDTRLNKGRPTRLNKIDTRTESTCDTRTESTTRORRESTRORRESUTRSTRESCTRSTRESNTRSTRESUTRSTATTRREASNDTRMETHODTRNAMTREVALTREVALIDEPOCHVISITNUMVISITTRDTCTRDY
1EX11111TR900111TARGETIMG-00001R-A1R-T01LPERPLongest Perpendicular17mm1717mm

MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTSCREEN10SCREENING2010-01-01-3
2EX11111TR900112TARGETIMG-00001R-A1R-T01LNSTATELymph Node StatePATHOLOGICAL
PATHOLOGICAL



MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTSCREEN10SCREENING2010-01-01-3
3EX11111TR900113TARGETIMG-00002R-A1R-T02LPERPLongest Perpendicular16mm1616mm

CT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTSCREEN10SCREENING2010-01-02-2
4EX11111TR900114TARGETIMG-00002R-A1R-T02LNSTATELymph Node StatePATHOLOGICAL
PATHOLOGICAL



CT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTSCREEN10SCREENING2010-01-02-2
5EX11111TR900115TARGETIMG-00001R-A1R-T03LDIAMLongest Diameter15mm1515mm

MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTSCREEN10SCREENING2010-01-01-3
6EX11111TR900116TARGETIMG-00003R-A1R-T04LDIAMLongest Diameter14mm1414mm

PHOTOGRAPHYRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTSCREEN10SCREENING2010-01-03-1
7EX11111TR900117TARGET
R-A1
SUMDIAMSum of Diameter62mm6262mm


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTSCREEN10SCREENING

8EX11111TR900118TARGET
R-A1
SUMNLNLDSum Diameters of Non Lymph Node Tumors29mm2929mm


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTSCREEN10SCREENING

9EX11111TR900119NON-TARGETIMG-00002R-A1R-NT01LNSTATELymph Node StatePATHOLOGICAL
PATHOLOGICAL



CT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTSCREEN10SCREENING2010-01-02-2
10EX11111TR9001110NON-TARGETIMG-00001R-A1R-NT02TUMSTATETumor StatePRESENT
PRESENT



MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTSCREEN10SCREENING2010-01-01-3
11EX11111TR9001111TARGETIMG-00004R-A2R-T01LPERPLongest Perpendicular12mm1212mm

MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT40WEEK 62010-02-1543
12EX11111TR9001112TARGETIMG-00004R-A2R-T01LNSTATELymph Node StatePATHOLOGICAL
PATHOLOGICAL



MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT40WEEK 62010-02-1543
13EX11111TR9001113TARGETIMG-00005R-A2R-T02LPERPLongest Perpendicular12mm1212mm

CT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT40WEEK 62010-02-1644
14EX11111TR9001114TARGETIMG-00005R-A2R-T02LNSTATELymph Node StatePATHOLOGICAL
PATHOLOGICAL



CT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT40WEEK 62010-02-1644
15EX11111TR9001115TARGETIMG-00004R-A2R-T03LDIAMLongest Diameter14mm1414mm

MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT40WEEK 62010-02-1543
16EX11111TR9001116TARGET
R-A2R-T04LDIAMLongest Diameter




NOT DONESCAN NOT PERFORMEDPHOTOGRAPHYRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT40WEEK 6

17EX11111TR9001117TARGET
R-A2
SUMDIAMSum of Diameter52mm5252mm


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT40WEEK 6

18EX11111TR9001118TARGET
R-A2
SUMNLNLDSum Diameters of Non Lymph Node Tumors28mm2828mm


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT40WEEK 6

19EX11111TR9001119TARGET
R-R-A2
ACNSDAbsolute Change From Nadir in Sum of Diameter-10mm-10-10mm


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT40WEEK 6

20EX11111TR9001120TARGET
R-A2
PCBSDPercent Change From Baseline in Sum of Diameter




NOT DONEAt least one target lesions was not measured
RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT40WEEK 6

21EX11111TR9001121TARGET
R-A2
PCNSDPercent Change From Nadir in Sum of Diameter-16%-16-16%


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT40WEEK 6

22EX11111TR9001122NON-TARGETIMG-00005R-A2R-NT01LNSTATELymph Node State




NOT DONENOT EVALUABLECT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT40WEEK 62010-02-1644
23EX11111TR9001123NON-TARGETIMG-00004R-A2R-NT02TUMSTATETumor State




NOT DONENOT EVALUABLEMRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT40WEEK 62010-02-1543
24EX11111TR9001124TARGETIMG-00007R-A3R-T01LPERPLongest Perpendicular12mm1212mm

MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT60WEEK 122010-03-2985
25EX11111TR9001125TARGETIMG-00007R-A3R-T01LNSTATELymph Node StatePATHOLOGICAL
PATHOLOGICAL



MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT60WEEK 122010-03-2985
26EX11111TR9001126TARGETIMG-00008R-A3R-T02LPERPLongest Perpendicular12mm1212mm

CT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT60WEEK 122010-03-3086
27EX11111TR9001127TARGETIMG-00008R-A3R-T02LNSTATELymph Node StatePATHOLOGICAL
PATHOLOGICAL



CT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT60WEEK 122010-03-3086
28EX11111TR9001128TARGETIMG-00007R-A3R-T03LDIAMLongest Diameter15mm1515mm

MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT60WEEK 122010-03-2985
29EX11111TR9001129TARGETIMG-00009R-A3R-T04

LDIAM

Longest Diameter8mm88mm

PHOTOGRAPHYRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT60WEEK 122010-04-0187
30EX11111TR9001130TARGET
R-A3
SUMDIAMSum of Diameter47mm4747mm


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT60WEEK 12

31EX11111TR9001131TARGET
R-A3
SUMNLNLDSum Diameters of Non Lymph Node Tumors23mm2323mm


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT60WEEK 12

32EX11111TR9001132TARGET
R-R-A3
ACNSDAbsolute Change From Nadir in Sum of Diameter-5mm-5-5mm


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT60WEEK 12

33EX11111TR9001133TARGET
R-A3
PCBSDPercent Change From Baseline in Sum of Diameter-24%-24-24%


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT60WEEK 12

34EX11111TR9001134TARGET
R-A3
PCNSDPercent Change From Nadir in Sum of Diameter-9%-9-9%


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT60WEEK 12

35EX11111TR9001135NON-TARGETIMG-00008R-A3R-NT01LNSTATELymph Node StateNON-PATHOLOGICAL
NON-PATHOLOGICAL



CT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT60WEEK 122010-03-3086
36EX11111TR9001136NON-TARGETIMG-00007R-A3R-NT02TUMSTATETumor StatePRESENT
PRESENT



MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT60WEEK 122010-03-3086
37EX11111TR9001137TARGETIMG-00010R-A4R-T01LPERPLongest Perpendicular9mm99mm

MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT80WEEK 202010-05-27144
38EX11111TR9001138TARGETIMG-00010R-A4R-T01LNSTATELymph Node StateNON-PATHOLOGICAL
NON-PATHOLOGICAL



MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT80WEEK 202010-05-27144
39EX11111TR9001139TARGETIMG-00011R-A4R-T02LPERPLongest Perpendicular12mm1212mm

CT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT80WEEK 202010-05-28145
40EX11111TR9001140TARGETIMG-00011R-A4R-T02LNSTATELymph Node StatePATHOLOGICAL
PATHOLOGICAL



CT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT80WEEK 202010-05-28145
41EX11111TR9001141TARGETIMG-00010R-A4R-T03LDIAMLongest Diameter11mm1111mm

MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT80WEEK 202010-05-27144
42EX11111TR9001142TARGETIMG-00012R-A4R-T04LDIAMLongest Diameter5mm55mm

PHOTOGRAPHYRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT80WEEK 202010-05-30147
43EX11111TR9001143TARGET
R-A4
SUMDIAMSum of Diameter37mm3737mm


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT80WEEK 202010-05-30147
44EX11111TR9001144TARGET
R-A4
SUMNLNLDSum Diameters of Non Lymph Node Tumors16mm1616mm


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT80WEEK 20

45EX11111TR9001145TARGET
R-A4
ACNSDAbsolute Change From Nadir in Sum of Diameter-10mm-10-10mm


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT80WEEK 20

46EX11111TR9001146TARGET
R-A4
PCBSDPercent Change From Baseline in Sum of Diameter-40%-40-40%


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT80WEEK 20

47EX11111TR9001147TARGET
R-A4
PCNSDPercent Change From Nadir in Sum of Diameter-21%-21-21%


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT80WEEK 20

48EX11111TR9001148NON-TARGETIMG-00011R-A4R-NT01LNSTATELymph Node StateNON-PATHOLOGICAL
NON-PATHOLOGICAL



CT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT80WEEK 202010-05-28145
49EX11111TR9001149NON-TARGETIMG-00010R-A4R-NT02TUMSTATETumor StatePRESENT
PRESENT



MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT80WEEK 202010-05-27144
50EX11111TR9001150TARGETIMG-00013R-A5R-T01LPERPLongest Perpendicular9mm99mm

MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT100WEEK 282010-07-23201
51EX11111TR9001151TARGETIMG-00013R-A5R-T01LPERPLongest PerpendicularNON-PATHOLOGICAL
NON-PATHOLOGICAL



MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT100WEEK 282010-07-23201
52EX11111TR9001152TARGETIMG-00014R-A5R-T02LDIAMLongest Diameter8mm88mm

CT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT100WEEK 282010-07-24202
53EX11111TR9001153TARGETIMG-00014R-A5R-T02LNSTATELymph Node StateNON-PATHOLOGICAL
NON-PATHOLOGICAL



CT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT100WEEK 282010-07-24202
54EX11111TR9001154TARGETIMG-00013R-A5R-T03LDIAMLongest Diameter6mm66mm

MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT100WEEK 282010-07-23201
55EX11111TR9001155TARGETIMG-00015R-A5R-T04LDIAMLongest Diameter0mm00mm

PHOTOGRAPHYRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT100WEEK 282010-07-25203
56EX11111TR9001156TARGET
R-A5
SUMDIAMSum of Diameter23mm2323mm


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT100WEEK 28

57EX11111TR9001157TARGET
R-A5
SUMNLNLDSum Diameters of Non Lymph Node Tumors6mm66mm


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT100WEEK 28

58EX11111TR9001158TARGET
R-A5
ACNSDAbsolute Change From Nadir in Sum of Diameter-14mm-14-14mm


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT100WEEK 28

59EX11111TR9001159TARGET
R-A5
PCBSDPercent Change From Baseline in Sum of Diameter-62%-62-62%


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT100WEEK 28

60EX11111TR9001160TARGET
R-A5
PCNSDPercent Change From Nadir in Sum of Diameter-37%-37-37%


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT100WEEK 28

61EX11111TR9001161NON-TARGETIMG-00014R-A5R-NT01LNSTATELymph Node StateNON-PATHOLOGICAL
NON-PATHOLOGICAL



CT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT100WEEK 282010-07-24202
62EX11111TR9001162NON-TARGETIMG-00013R-A5R-NT02TUMSTATETumor StatePRESENT
PRESENT



MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT100WEEK 282010-07-23201
63EX11111TR9001163TARGETIMG-00016R-A6R-T01LPERPLongest Perpendicular8mm88mm

MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT120WEEK 362010-09-17257
64EX11111TR9001164TARGETIMG-00016R-A6R-T01LNSTATELymph Node StateNON-PATHOLOGICAL
NON-PATHOLOGICAL



MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT120WEEK 362010-09-17257
65EX11111TR9001165TARGETIMG-00017R-A6R-T02LPERPLongest Perpendicular9mm99mm

CT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT120WEEK 362010-09-17257
66EX11111TR9001166TARGETIMG-00017R-A6R-T02LNSTATELymph Node StateNON-PATHOLOGICAL
NON-PATHOLOGICAL



CT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT120WEEK 362010-09-17257
67EX11111TR9001167TARGETIMG-00016R-A6R-T03LDIAMLongest Diameter0mm00mm

MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT120WEEK 362010-09-17257
68EX11111TR9001168TARGETIMG-00018R-A6R-T04LDIAMLongest Diameter0mm00mm

PHOTOGRAPHYRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT120WEEK 362010-09-17257
69EX11111TR9001169TARGET
R-A6
SUMDIAMSum of Diameter17mm1717mm


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT120WEEK 36

70EX11111TR9001170TARGET
R-A6
SUMNLNLDSum Diameters of Non Lymph Node Tumors0mm00mm


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT120WEEK 36

71EX11111TR9001171TARGET
R-A6
ACNSDAbsolute Change From Nadir in Sum of Diameter-6mm-6-6mm


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT120WEEK 36

72EX11111TR9001172TARGET
R-A6
PCBSDPercent Change From Baseline in Sum of Diameter-72%-72-72%


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT120WEEK 36

73EX11111TR9001173TARGET
R-A6
PCNSDPercent Change From Nadir in Sum of Diameter-26%-26-26%


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT120WEEK 36

74EX11111TR9001174NON-TARGETIMG-00017R-A6R-NT01LNSTATELymph Node StateNON-PATHOLOGICAL
NON-PATHOLOGICAL



CT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT120WEEK 362010-09-17257
75EX11111TR9001175NON-TARGETIMG-00016R-A6R-NT02TUMSTATETumor StateABSENT
ABSENT



MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT120WEEK 362010-09-17257
76EX11111TR9001176NEWIMG-00017R-A6R-NEW01TUMSTATETumor StateEQUIVOCAL
EQUIVOCAL



CT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT120WEEK 362010-09-17257
77EX11111TR9001177TARGETIMG-00019R-A7R-T01LPERPLongest Perpendicular12mm1212mm

MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 442010-11-15314
78EX11111TR9001178TARGETIMG-00019R-A7R-T01LNSTATELymph Node StatePATHOLOGICAL
PATHOLOGICAL



MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 442010-11-15314
79EX11111TR9001179TARGETIMG-00020R-A7R-T02LPERPLongest Perpendicular9mm99mm

CT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 442010-11-14313
80EX11111TR9001180TARGETIMG-00020R-A7R-T02LNSTATELymph Node StateNON-PATHOLOGICAL
NON-PATHOLOGICAL



CT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 442010-11-14313
81EX11111TR9001181TARGETIMG-00019R-A7R-T03LDIAMLongest Diameter0mm00mm

MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 442010-11-15314
82EX11111TR9001182TARGETIMG-00021R-A7R-T04LDIAMLongest Diameter0mm00mm

PHOTOGRAPHYRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 442010-11-16315
83EX11111TR9001183TARGET
R-A7
SUMDIAMSum of Diameter21mm2121mm


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 44

84EX11111TR9001184TARGET
R-A7
SUMNLNLDSum Diameters of Non Lymph Node Tumors0mm00mm


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 44

85EX11111TR9001185TARGET
R-A7
ACNSDAbsolute Change From Nadir in Sum of Diameter4mm44mm


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 44

86EX11111TR9001186TARGET
R-A7
PCBSDPercent Change From Baseline in Sum of Diameter-66%-66-66%


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 44

87EX11111TR9001187TARGET
R-A7
PCNSDPercent Change From Nadir in Sum of Diameter23%2323%


RADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 44

88EX11111TR9001188NON-TARGETIMG-00020R-A7R-NT01LNSTATELymph Node StateNON-PATHOLOGICAL
NON-PATHOLOGICAL



CT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 442010-11-15314
89EX11111TR9001189NON-TARGETIMG-00019R-A7R-NT02TUMSTATETumor StatePRESENT
PRESENT



MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 442010-11-14313
90EX11111TR9001190NEWIMG-00020R-A7R-NEW01LDIAMLongest Diameter8mm88mm

CT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 442010-11-15314
91EX11111TR9001191NEWIMG-00020R-A7R-NEW01TUMSTATETumor StateUNEQUIVOCAL
UNEQUIVOCAL



CT SCANRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 442010-11-15314
92EX11111TR9001192NEWIMG-00019R-A7R-NEW02LDIAMLongest Diameter6mm66mm

MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 442010-11-14313
93EX11111TR9001193NEWIMG-00019R-A7R-NEW02TUMSTATETumor StateUNEQUIVOCAL
UNEQUIVOCAL



MRIRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 442010-11-14313
94EX11111TR9001194NEWIMG-00022R-A7R-NEW03LNSTATELymph Node StatePATHOLOGICAL
PATHOLOGICAL



ULTRASOUNDRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 442010-11-16315

...

Dataset wrap
Namepr
Rowcaps
Rows 1-3: Show the scans preformed at screening. The results of the scans are record in TU and TR.
Rows 4-21: Show the scans preformed at weeks 6, 12, 20, 28, 36 and 44. The results of the scans are record in TU and TR.
Dataset2
RowSTUDYIDDOMAINUSUBJIDPRSEQPRREFIDPRLNKGRPPRTRTPRLOCPRNAMPREVALPREVALIDEPOCHVISITNUMVISITPRSTDTCPRSTDY
1EX11111PR900111IMG-00001R-A1MRIHEAD AND NECKRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTSCREEN10SCREENING2010-01-01-3
2EX11111PR900112IMG-00002R-A1CT SCANCHESTRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTSCREEN10SCREENING2010-01-02-2
3EX11111PR900113IMG-00003R-A1PHOTOGRAPHYSKIN OF THE TRUNKRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTSCREEN10SCREENING2010-01-03-1
4EX11111PR900114IMG-00004R-A2MRIHEAD AND NECKRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT40WEEK 62010-02-1543
5EX11111PR900115IMG-00005R-A2CT SCANCHESTRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT40WEEK 62010-02-1644
6EX11111PR900116IMG-00007R-A3MRIHEAD AND NECKRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT60WEEK 122010-03-2985
7EX11111PR900117IMG-00008R-A3CT SCANCHESTRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT60WEEK 122010-03-3086
8EX11111PR900118IMG-00009R-A3PHOTOGRAPHYSKIN OF THE TRUNKRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT60WEEK 122010-04-0187
9EX11111PR900119IMG-00010R-A4MRIHEAD AND NECKRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT80WEEK 202010-05-27144
10EX11111PR9001110IMG-00011R-A4CT SCANCHESTRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT80WEEK 202010-05-28145
11EX11111PR9001111IMG-00012R-A4PHOTOGRAPHYSKIN OF THE TRUNKRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT80WEEK 202010-05-30147
12EX11111PR9001112IMG-00013R-A5MRIHEAD AND NECKRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT100WEEK 282010-07-23201
13EX11111PR9001113IMG-00014R-A5CT SCANCHESTRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT100WEEK 282010-07-24202
14EX11111PR9001114IMG-00015R-A5PHOTOGRAPHYSKIN OF THE TRUNKRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT100WEEK 282010-07-25203
15EX11111PR9001115IMG-00016R-A6MRIHEAD AND NECKRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT120WEEK 362010-09-17257
16EX11111PR9001116IMG-00017R-A6CT SCANCHESTRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT120WEEK 362010-09-17257
17EX11111PR9001117IMG-00018R-A6PHOTOGRAPHYSKIN OF THE TRUNKRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT120WEEK 362010-09-17257
18EX11111PR9001118IMG-00019R-A7MRIHEAD AND NECKRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 442010-11-14313
19EX11111PR9001119IMG-00020R-A7CT SCANCHESTRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 442010-11-15314
20EX11111PR9001120IMG-00021R-A7PHOTOGRAPHYSKIN OF THE TRUNKRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 442010-11-16315
21EX11111PR9001121IMG-00022R-A7ULTRASOUNDPELVISRADIOL. INC.INDEPENDENT ASSESSORRADIOLOGISTTREATMENT140WEEK 442010-11-16315

...

Dataset wrap
Namerelrec
Rowcaps
Rows 1-2: Show the one-to-many relationship between TU and TR using --LNKID. --LNKID is the tumor identifier.  The matching RELID value indicates that the two rows form the relationship.
Rows 3-4: Show the many-to-one relationship between TR and RS using --LNKGRP. --LNKGRP is the identifier used to group and link all of the measurement/assessment records used in the assessment of the overall response record in the RS domain. The matching RELID value indicates that the two rows form the relationship.
Rows 5-6: Show the one-to-many relationship between TU and PR using --REFID. --REFID contains the image identifier. The matching RELID value indicates that the two rows form the relationship.
Dataset2
RowSTUDYIDRDOMAINUSUBJIDIDVARIDVARVALRELTYPERELID
1ABC12345TU
TULNKID
OneTUTR1
2ABC12345TR
TRLNKID
ManyTUTR1
3ABC12345TR
TRLNKGRP
ManyTRRS1
4ABC12345RS
RSLNKGRP
OneTRRS1
5ABC12345PR
PRREFID
OnePRTU1
6ABC12345TU
TUREFID
ManyPRTU1

...